Cargando…
Botanical identification of plants described in Mādhava Cikitsā for the treatment of diarrhoea
CONTEXT: Mādhava is regarded as a 7(th) century Indian Physician who composed two treatises (in Sanskrit) on Ayurveda, the Mādhava Nidāna and Mādhava Cikitsā. The former treatise deals with the diagnosis of diseases while the latter with the treatment using medicinal plants and other recipes. In Mād...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995852/ https://www.ncbi.nlm.nih.gov/pubmed/27621515 http://dx.doi.org/10.4103/0257-7941.188179 |
Sumario: | CONTEXT: Mādhava is regarded as a 7(th) century Indian Physician who composed two treatises (in Sanskrit) on Ayurveda, the Mādhava Nidāna and Mādhava Cikitsā. The former treatise deals with the diagnosis of diseases while the latter with the treatment using medicinal plants and other recipes. In Mādhava Cikitsā, a common Sanskrit name is found to describe two or more totally different botanical plant species (thus leading to ambiguity) and a distinct botanical species is also found to represent two or more Sanskrit names at several instances. AIMS: The present paper deals with the correct botanical identification (most probable) of Sanskrit named plants described in Mādhava Cikitsā for the treatment of Diarrhoea (Atisāra Cikitsā). SUBJECTS AND METHODS: The authentic manuscripts of ‘Mādhava Cikitsā’ were critically studied for the present research outcome. A detailed literature survey is carried out from various references and texts. RESULTS: The list of Sanskrit named plants contains 103 names, while after the critical study and assigning the most probable botanical identification as per ICBN, the list of plant species described in the text for the treatment of Diarrhoea is found to contain 73 names. CONCLUSIONS: The present study will certainly benefit Ayurvedic medical practitioners and pharmaceutical companies in selection of proper plant species avoiding substitutions for drug formulation. |
---|